Immunovant
IMVT | NASDAQ
$33.28
-$0.90 (-2.63%)
At close: Nov 16, 2026, 4:00 PM ET
$33.28
$0.00 (0.00%)
After-hours:
Nov 16, 2026, 7:30 PM ET
Immunovant Statistics
Key statistics explainedMarket Data
$6.89B
$6.16B
0.84
1.31M
206.67M
19.02%
54.04%
NASDAQ
US45258J1025
Price Performance
24.5%
-23.9%
25.4%
30.9%
37.0%
-1.6%
320.7%
24.5%
40.2%
33.3%
18.1%
Valuation
-13.00
N/A
-1.40
2.01
970.71
1,036.50
10.48
-17.44
-15.44
-17.42
868.91
-12.08
-12.09
-15.61
-7.7%
-5.7%
-6.5%
Financial Health
$722.27M
$0
$722.27M
$760.97M
7.31
7.31
0.00
-0.00
-0.00
N/A
0.00
35.96
3
Margins & Profitability
100.0%
-7488.4%
-7186.4%
-7173.5%
-5567.5%
-6285.0%
717.6%
-12.9%
Returns
-66.9%
-63.0%
-80.7%
-80.9%
-66.9%
Historical Growth (CAGR)
150.0%
100.0%
N/A
-6.7%
-13.2%
N/A
-16.8%
-24.3%
N/A
Analyst Forecasts
Buy
9
14.7%
281.2%
Feb 5, 2027
-$0.68
11.5%
N/A
N/A
Fair Value Estimates
N/A
N/A
N/A
N/A
$40.00
20.2%
Cash Flow
$-395M
$-395.01M
$-445.92M
-$1.91
-$1.91
-5567.4%
Income Statement
$7.1M
$7.1M
$-531.3M
$-509.88M
$-508.96M
-$2.56
$22.52K
$-1.62M
315
Add to Watchlist
Select watchlists to add or remove IMVT